Abstract:Background Kabuki syndrome type 1 (KS1), a rare multisystem congenital disorder, presents with characteristic facial features, intellectual disability, persistent fetal fingertip pads, skeletal abnormalities, and postnatal growth delays. KS1 results from pathogenic variants in the KMT2D gene, which encodes a histone methyltransferase protein involved in chromatin remodeling, promoter and enhancer regulation, and scaffold formation during early development. KMT2D also mediates cell signaling pathways, responding to external stimuli and organizing effector protein assembly. Research on KMT2D's molecular mechanisms in KS1 has primarily focused on its histone methyltransferase activity, leaving a gap in understanding the methyltransferase‐independent roles in KS1 clinical manifestations. Methods This scoping review examines KMT2D's role in gene expression regulation across various species, cell types, and contexts. We analyzed human pathogenic KMT2D variants using publicly available databases and compared them to research organism models of KS1. We also conducted a systematic search of healthcare and governmental databases for clinical trials, studies, and therapeutic approaches. Results Our review highlights KMT2D's critical roles beyond methyltransferase activity in diverse cellular contexts and conditions. We identified six distinct groups of KMT2D as a cell signaling mediator, including evidence of methyltransferase‐dependent and ‐independent activity. A comprehensive search of the literature, clinical databases, and public registries emphasizes the need for basic research on KMT2D's functional complexity and longitudinal studies of KS1 patients to establish objective outcome measurements for therapeutic development. Conclusion We discuss how KMT2D's role in translating external cellular communication can partly explain the clinical heterogeneity observed in KS1 patients. Additionally, we summarize the current molecular diagnostic approaches and clinical trials targeting KS1. This review is a resource for patient advocacy groups, researchers, and physicians to support KS1 diagnosis and therapeutic development.

Molecular basis of the scalp-ear-nipple syndrome unraveled by the characterization of disease-causing KCTD1 mutants

Structural studies of KCTD1 and its disease-causing mutant P20S provide insights into the protein function and misfunction

Integrated Facial Analysis and Targeted Sequencing Identifies a Novel KDM6A Pathogenic Variant Resulting in Kabuki Syndrome

BTB domain mutations perturbing KCTD15 oligomerisation cause a distinctive frontonasal dysplasia syndrome

A novel mutation in the BTB domain impairs transcriptional repression function of KCTD1 leading to syndromic microtia

KCTD1 and Scalp-Ear-Nipple ('Finlay-Marks') syndrome may be associated with myopia and Thin basement membrane nephropathy through an effect on the collagen IV α3 and α4 chains

Next-Generation Sequencing Detection and Characterization of A Heterozygous Novel Splice Junction Mutation in the 2b Domain of Krt1 in A Family with Diffuse Palmoplantar Keratoderma

Characterizing the molecular impact of KMT2D variants on the epigenetic and transcriptional landscapes in Kabuki Syndrome

In Silico Predicted Structural and Functional Insights of All Missense Mutations on 2B Domain of K1/K10 Causing Genodermatoses

KCTD: A New Gene Family Involved in Neurodevelopmental and Neuropsychiatric Disorders

Molecular insights of KMT2D and clinical aspects of Kabuki syndrome type 1

Biallelic Loss of Function Variants in SENP7 Cause Immunodeficiency with Neurologic and Muscular Phenotypes

Aplasia Cutis Congenita Pathomechanisms Reveal Key Regulators of Skin and Skin Appendage Morphogenesis

Potassium Channel KCNH1 Activating Variants Cause Altered Functional and Morphological Ciliogenesis

The KMT2D Kabuki syndrome histone methylase controls neural crest cell differentiation and facial morphology

A novel 11 base pair deletion in KMT2C resulting in Kleefstra syndrome 2

RAP1-mediated MEK/ERK Pathway Defects in Kabuki Syndrome.

Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity

Clinical Phenotypes and Molecular Findings in Ten Chinese Patients with Kleefstra Syndrome Type 1 Due to EHMT1 Defects.

Patients with KCNH1-related intellectual disability without distinctive features of Zimmermann-Laband/Temple-Baraitser syndrome

Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice